| Role |
Name |
Disclosure |
Details |
| Author | Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School | Nothing to disclose | Details | | Medical Editor | Mark G Lebwohl, MD, Chairman, Department of Dermatology, Mount Sinai School of Medicine | Abbott Laboratories Actelion Amgen Astellas Basilea Briston-Myers Squibb Celtic Pharma Centocor Chattem DermiPsor DOV Galderma Genentech Genzyme Graceway Helix BioMedix Medicis Novartis OMP Pfizer PharmaDerm Stiefel Teva UCB Warner Chilcott Peplin Ranbaxy | Details | | Pharmacy Editor | David F Butler, MD, Professor of Dermatology, Texas A&M University College of Medicine; Director, Division of Dermatology, Scott and White Clinic; Director Dermatology Residency Training Program, Scott and White Clinic | 3M Pharmaceutical Graceway Pharmaceuticals | Details | | Managing Editor | Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine | Amgen Abbott Electrical Optical Sciences Centocor | Details | | CME Editor | Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital | Nothing to disclose | Details | | Chief Editor | William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System | elsevier american college of physicians | Details |
|